Skip to Main Content
Contribute Try STAT+ Today

Rise and shine, another busy day is on the way. We can tell because our official mascot is bounding about the castle at high speed, eager for a stroll about the neighborhood. Happily, Mrs. Pharmalot is pitching in. As for us, we are recovering after a brief trip where we met interesting people and are now recovering with a needed cup or three of stimulation. Our choice this morning is pumpkin spice with a spot of almond milk. Yum. Meanwhile, here is the usual menu of tidbits. We hope you have a smashing day and, as always, do keep in touch. …

The U.S. National Institutes of Health scientists played “a major role” in developing the Moderna (MRNA) Covid-19 vaccine and NIH Director Francis Collins says the agency intends to defend its claim as co-owner of patents on the shot, Reuters writes. Moderna excluded three NIH scientists as co-inventors of a central patent for its vaccine in its application filed in July. Moderna expects 2021 sales of $15 billion to $18 billion from the COVID-19 vaccine — its first and only commercial product — and up to $22 billion next year. Moderna acknowledged that NIH scientists played a “substantial role” in developing the vaccine, but disagrees with NIH patent claims.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment